Skip to main content
$14.77 +0.09 (+0.61%) At close · Jul 24
Market Cap
$504.93M
Shares
34.09M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$99.99M +25.1%
FY2025 Revenue FY2020–FY2025
Net Income
-$21.47M +20.9%
FY2025 Net Income FY2020–FY2025
Gross Margin
77.23% +3.3pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
-16.34% +10.8pp
FY2025 Operating Margin FY2020–FY2025
Diluted EPS
-$0.66 +29%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$11.01M +38.7%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
$99M – $101M $99.53M $99.99MG $79.91M $65.42M $45.52M $45.18M $41.14M
$21.6M $22.77M $20.82M $17.3M $13.03M $11.75M $10.87M
$77.93M $77.22M $59.09M $48.12M $32.49M $33.44M $30.27M
77.23% 73.94% 73.56% 71.38% 74% 73.59%
$27.64M $27.89M $23.65M $20.78M $21.95M $18.21M $15.7M
$47.16M $46.58M $39.67M
$19.89M $19.09M $17.43M
$57.05M $57.1M $54.52M $51.34M $38.96M $27.63M
$94.69M $93.56M $80.76M $75.3M $73.29M $57.17M $43.32M
-$16.76M -$16.34M -$21.67M -$27.17M -$40.79M -$23.74M -$13.05M
-16.34% -27.12% -41.54% -89.62% -52.54% -31.72%
$6.83M $7.46M $8.8M $8.52M $7.53M $7.41M $11.49M
$2.59M $2.82M $3.02M $3.05M $1.58M $448K $41K
-$569K -$486K $304K -$315K -$337K -$5.38M $218K
$0 $0
-$21.57M -$21.47M -$27.14M -$32.96M -$47.08M -$36.08M -$24.28M
-21.47% -33.97% -50.38% -103.43% -79.85% -59.02%
-$21.57M -$21.47M -$27.14M -$32.96M -$47.08M -$36.08M -$24.05M
-$29.9M -$32.96M -$47.92M -$36.39M -$24.25M
USD/shares -$0.66 -$0.93 -$1.27 -$1.91 -$2.17 -$117.85
USD/shares -$0.66 -$0.93 -$1.27 -$1.91 -$2.17 -$117.85
shares 32.72M 29.13M 25.85M 24.59M 16.61M 204.07K
shares 32.72M 29.13M 25.85M 24.59M 16.61M 204.07K
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: $49.55M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Medical Devices median 2.14×
EV/EBIT
Medical Devices median 21.03×
P/E (TTM)
Medical Devices median 27.62×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component FY2025 FY2024 FY2023
Non Us $900,000 $200,000 $100,000
Key facts CIK 1528287 CUSIP 641288105 13F (30d) 9 filings 9 filers Visit website Investor relations